Published in Eur J Neurosci on March 01, 2011
The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building? Neuropharmacology (2011) 1.36
Neuropathology of stress. Acta Neuropathol (2013) 1.14
Oligodendrogenesis after cerebral ischemia. Front Cell Neurosci (2013) 1.06
Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link? Mol Neurobiol (2012) 1.04
Prospective isolation of adult neural stem cells from the mouse subependymal zone. Nat Protoc (2011) 1.03
Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiol Dis (2012) 0.98
Neural stem cells: mechanisms and modeling. Protein Cell (2012) 0.91
Adult neurogenesis transiently generates oxidative stress. PLoS One (2012) 0.90
The impact of expertise in olfaction. Front Psychol (2013) 0.90
Stress, glucocorticoid receptors, and adult neurogenesis: a balance between excitation and inhibition? Cell Mol Life Sci (2014) 0.86
Exosomes in stroke pathogenesis and therapy. J Clin Invest (2016) 0.84
Memory development: implications for adults recalling childhood experiences in the courtroom. Nat Rev Neurosci (2013) 0.83
Temporal features of adult neurogenesis: differences and similarities across mammalian species. Front Neurosci (2013) 0.81
N-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidence. CNS Neurol Disord Drug Targets (2013) 0.80
Targeting nitric oxide in the subacute restorative treatment of ischemic stroke. Expert Opin Investig Drugs (2013) 0.79
Thymosin beta 4 up-regulates miR-200a expression and induces differentiation and survival of rat brain progenitor cells. J Neurochem (2015) 0.79
Function of neural stem cells in ischemic brain repair processes. J Cereb Blood Flow Metab (2016) 0.78
Pre- and perinatal hypoxia associated with hippocampus/amygdala volume in bipolar disorder. Psychol Med (2013) 0.78
Numb and Alzheimer's disease: the current picture. Front Neurosci (2012) 0.76
Neural stem cells respond to stress hormones: distinguishing beneficial from detrimental stress. Front Physiol (2015) 0.76
Increased Olfactory Bulb BDNF Expression Does Not Rescue Deficits in Olfactory Neurogenesis in the Huntington's Disease R6/2 Mouse. Chem Senses (2016) 0.75
Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice. Nat Neurosci (2017) 0.75
How close is the stem cell cure to the Alzheimer's disease: Future and beyond? Neural Regen Res (2012) 0.75
Neuropsychiatry: where are we and where do we go from here? Mens Sana Monogr (2013) 0.75
The dynamics of adult neurogenesis in human hippocampus. Neural Regen Res (2016) 0.75
Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science (2007) 5.23
Regional and cellular gene expression changes in human Huntington's disease brain. Hum Mol Genet (2006) 3.91
Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol (2006) 3.72
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet (2007) 2.54
Complex reorganization and predominant non-homologous repair following chromosomal breakage in karyotypically balanced germline rearrangements and transgenic integration. Nat Genet (2012) 2.45
Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc Natl Acad Sci U S A (2003) 2.36
Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci U S A (2013) 2.21
Population-specific expression analysis (PSEA) reveals molecular changes in diseased brain. Nat Methods (2011) 1.70
A role for human brain pericytes in neuroinflammation. J Neuroinflammation (2014) 1.64
DNA instability in postmitotic neurons. Proc Natl Acad Sci U S A (2008) 1.61
Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain. Brain Res (2007) 1.50
Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice. Neurobiol Dis (2008) 1.38
The effect of neurodegenerative diseases on the subventricular zone. Nat Rev Neurosci (2007) 1.28
An ovine transgenic Huntington's disease model. Hum Mol Genet (2010) 1.24
Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data. BMC Bioinformatics (2006) 1.24
Distinct neuroinflammatory profile in post-mortem human Huntington's disease. Neuroreport (2009) 1.23
Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc Natl Acad Sci U S A (2002) 1.22
GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function. Brain Res Mol Brain Res (2003) 1.20
Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain. Eur J Neurosci (2004) 1.18
The cellular composition and morphological organization of the rostral migratory stream in the adult human brain. J Chem Neuroanat (2008) 1.17
Cholinergic neuronal defect without cell loss in Huntington's disease. Hum Mol Genet (2006) 1.17
Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease. Brain Res (2006) 1.15
Glutamate uptake is reduced in prefrontal cortex in Huntington's disease. Neurochem Res (2007) 1.10
Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo. J Neurosci (2010) 1.10
Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. Brain (2010) 1.08
Localization of glycine receptors in the human forebrain, brainstem, and cervical spinal cord: an immunohistochemical review. Front Mol Neurosci (2009) 1.04
Striosomes and mood dysfunction in Huntington's disease. Brain (2006) 1.02
Progenitor cells and adult neurogenesis in neurodegenerative diseases and injuries of the basal ganglia. Clin Exp Pharmacol Physiol (2007) 1.01
Immunohistochemical staining of post-mortem adult human brain sections. Nat Protoc (2006) 1.01
Assessing RNA quality in postmortem human brain tissue. Exp Mol Pathol (2007) 0.99
Loss of SNAP-25 and rabphilin 3a in sensory-motor cortex in Huntington's disease. J Neurochem (2007) 0.97
Neurogenesis and progenitor cells in the adult human brain: a comparison between hippocampal and subventricular progenitor proliferation. Dev Neurobiol (2012) 0.96
M-CSF increases proliferation and phagocytosis while modulating receptor and transcription factor expression in adult human microglia. J Neuroinflammation (2013) 0.96
Extracellular signal-regulated kinase involvement in human astrocyte migration. Brain Res (2007) 0.92
Insoluble TATA-binding protein accumulation in Huntington's disease cortex. Brain Res Mol Brain Res (2002) 0.92
The transcription factor PU.1 is critical for viability and function of human brain microglia. Glia (2013) 0.91
Molecular investigation of TBP allele length: a SCA17 cellular model and population study. Neurobiol Dis (2003) 0.90
ABC efflux transporters in brain vasculature of Alzheimer's subjects. Brain Res (2010) 0.90
N-terminal tripeptide of IGF-1 improves functional deficits after 6-OHDA lesion in rats. Neuroreport (2004) 0.90
Adult human glia, pericytes and meningeal fibroblasts respond similarly to IFNy but not to TGFβ1 or M-CSF. PLoS One (2013) 0.89
The rostral migratory stream and olfactory system: smell, disease and slippery cells. Prog Brain Res (2009) 0.88
Cellular composition of human glial cultures from adult biopsy brain tissue. J Neurosci Methods (2007) 0.88
Identification and characterization of a novel splice variant of the metabotropic glutamate receptor 5 gene in human hippocampus and cerebellum. Brain Res Mol Brain Res (2002) 0.88
Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia. Mov Disord (2013) 0.88
A histochemical and immunohistochemical analysis of the subependymal layer in the normal and Huntington's disease brain. J Chem Neuroanat (2005) 0.87
Comparative cellular distribution of GABAA and GABAB receptors in the human basal ganglia: immunohistochemical colocalization of the alpha 1 subunit of the GABAA receptor, and the GABABR1 and GABABR2 receptor subunits. J Comp Neurol (2004) 0.87
Sox-2 is expressed by glial and progenitor cells and Pax-6 is expressed by neuroblasts in the human subventricular zone. Exp Neurol (2006) 0.87
Adult human brain neural progenitor cells (NPCs) and fibroblast-like cells have similar properties in vitro but only NPCs differentiate into neurons. PLoS One (2012) 0.87
Valproic acid induces microglial dysfunction, not apoptosis, in human glial cultures. Neurobiol Dis (2010) 0.86
Isolation and culture of adult human microglia within mixed glial cultures for functional experimentation and high-content analysis. Methods Mol Biol (2013) 0.86
Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautography. Brain Res (2010) 0.84
High-throughput quantification of Alzheimer's disease pathological markers in the post-mortem human brain. J Neurosci Methods (2008) 0.83
A method for generating high-yield enriched neuronal cultures from P19 embryonal carcinoma cells. J Neurosci Methods (2011) 0.83
TBP, a polyglutamine tract containing protein, accumulates in Alzheimer's disease. Brain Res Mol Brain Res (2004) 0.82
Glycine receptors in the striatum, globus pallidus, and substantia nigra of the human brain: an immunohistochemical study. J Comp Neurol (2007) 0.82
The Neuropathology of Huntington's Disease. Curr Top Behav Neurosci (2015) 0.82
Cortical interneuron loss and symptom heterogeneity in Huntington disease. Ann Neurol (2014) 0.81
Fragments of HdhQ150 mutant huntingtin form a soluble oligomer pool that declines with aggregate deposition upon aging. PLoS One (2012) 0.81
A novel population of progenitor cells expressing cannabinoid receptors in the subependymal layer of the adult normal and Huntington's disease human brain. J Chem Neuroanat (2006) 0.80
Neurogenesis in the diseased adult human brain--new therapeutic strategies for neurodegenerative diseases. Cell Cycle (2003) 0.80
Distribution of the creatine transporter throughout the human brain reveals a spectrum of creatine transporter immunoreactivity. J Comp Neurol (2014) 0.80
Aggregate distribution in frontal and motor cortex in Huntington's disease brain. Neuroreport (2006) 0.79
Decreased Lin7b expression in layer 5 pyramidal neurons may contribute to impaired corticostriatal connectivity in huntington disease. J Neuropathol Exp Neurol (2010) 0.79
Insulin and IGF1 modulate turnover of polysialylated neural cell adhesion molecule (PSA-NCAM) in a process involving specific extracellular matrix components. J Neurochem (2013) 0.78
Dissociated expression of mitochondrial and cytosolic creatine kinases in the human brain: a new perspective on the role of creatine in brain energy metabolism. J Cereb Blood Flow Metab (2013) 0.77
Altered distribution of mGlu2 receptors in β-amyloid-affected brain regions of Alzheimer cases and aged PS2APP mice. Brain Res (2010) 0.77
Identifying neural progenitor cells in the adult human brain. Methods Mol Biol (2013) 0.76
GABA(A) receptor characterization and subunit localization in the human sub-ventricular zone. J Chem Neuroanat (2013) 0.76
Selective neurodegeneration, neuropathology and symptom profiles in Huntington's disease. Adv Exp Med Biol (2012) 0.76
Recovery of neurological functions in non-human primate model of Parkinson's disease by transplantation of encapsulated neonatal porcine choroid plexus cells. J Parkinsons Dis (2013) 0.75
Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia. Metallomics (2017) 0.75